# Psilocybin for Major Depressive Disorder

> **NCT05675800** · PHASE2 · WITHDRAWN · sponsor: **Washington University School of Medicine**

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Psilocybin

## Key facts

- **NCT ID:** NCT05675800
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-01-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-03-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Resident who was tasked with coordinating this study is no longer able to do so.
- **Last updated:** 2024-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05675800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05675800, "Psilocybin for Major Depressive Disorder". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05675800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*